Columbia Partners Investment Management’s Pacira BioSciences PCRX Stock Holding History

Columbia Partners Investment Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-17,152	Closed	-$704K	–	366
2015 Q3	$704K	Sell	17,152 -744	-4%	-$45.6K	0.05%	317
2015 Q2	$1.26M	Sell	17,896 -2,004	-10%	-$158K	0.08%	226
2015 Q1	$1.77M	Sell	19,900 -274	-1%	-$27.8K	0.09%	206
2014 Q4	$1.79M	Sell	20,174 -10,212	-34%	-$966K	0.09%	200
2014 Q3	$2.94M	Sell	30,386 -14,722	-33%	-$1.43M	0.15%	172
2014 Q2	$4.14M	Buy	+45,108	New	+$3.43M	0.19%	158

Other funds holding PCRX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

MCM

Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

HCM

Hoplite Capital Management New York $15.1M AUM 27.41% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Columbia Partners Investment Management's PCRX Position: Q4 2015 in Review

Columbia Partners Investment Management sold out of Pacira BioSciences (PCRX) in Q4 2015, closing a stake of 17,152 shares — an estimated $704K sold.

Columbia Partners Investment Management first reported a position in PCRX in Q2 2014 and held it in 6 quarters. The position peaked at $4.14M in Q2 2014. 214 funds tracked by Wall St. Rank hold PCRX as of Q4 2015.

Columbia Partners Investment Management reported no remaining Pacira BioSciences position as of Q4 2015 after selling out during the quarter.
Columbia Partners Investment Management sold 17,152 Pacira BioSciences shares in Q4 2015, an estimated $704K.
Columbia Partners Investment Management first reported a position in Pacira BioSciences in Q2 2014 and held it in 6 quarters.
Columbia Partners Investment Management's Pacira BioSciences position peaked at $4.14M in Q2 2014.
214 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2015.

Based on Columbia Partners Investment Management's 13F filing for Q4 2015, filed 8 Feb 2016.